Evidence map›Paper›PMID 40151751›Full record

ArticleCureus2025

Retained Rim Enhancement in Mucinous Breast Cancer Suggests Aggressive Biology: A Case Report.

Harumasa Takahashi, Shoji Oura

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Harumasa TakahashiDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.
Shoji OuraDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 44-year-old premenopausal woman was referred to our hospital for a detailed examination of her left rapidly growing breast mass. Mammography only showed focal asymmetric density. Ultrasound showed a 14 mm oval mass with distinct borders, a high depth/width rate of 0.79, numerous punctate echogenic foci against background low echoes, and slightly enhanced posterior echoes. Magnetic resonance imaging (MRI) of the mass showed low signal intensity on T1-weighted images and high signal intensity with a slightly low signal intensity area in the mass center on fat-suppressed T2-weighted images. Subtraction MRI depicted early and retained rim enhancement patterns. The patient underwent a core needle biopsy of the breast mass. Pathological study showed that the tumor had atypical cells growing in a papillary fashion with abundant mucus, leading to the diagnosis of mucinous breast cancer. The patient, therefore, underwent breast-conserving surgery and sentinel node biopsy. A post-operative pathological study showed that the tumor had cancer cells mainly distributed in a ring fashion and extremely sparse cancer cells with thick fibrous septa in the mass center. Immunostaining showed that the mucinous breast cancer had estrogen and progesterone receptor positivities, human epidermal growth factor receptor type 2 equivocation, and a high Ki-labelling index of 50%. Diagnostic physicians should note that retained rim enhancement may predict the biological aggressiveness of mucinous breast cancers.

Indexed as

breast cancerhigh ki-67 labelling indexmucinous breast cancerretained rim enhancementthick fibrous septa

Identifiers

PMID40151751
PMCPMC11948909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.